| Name | Title | Contact Details |
|---|
At POCN, we seek to support the careers and clinical practices of NPs and PAs - Advanced Clinicians by partnering with life science companies who recognize their critical role on the front lines of healthcare. We are the largest network of Advanced Clinicians in the U.S. and strive to support and enable success for them at every turn. POCN provides Advanced Clinicians with an opportunity engine to grow their careers, earn valuable financial incentives, and increase their clinical knowledge and practice productivity. Recognizing the vital relationship between NPs, PAs, and the broader healthcare and life sciences industries, POCN specializes in developing peer–validated programs that include engaging live and virtual events, helpful patient education resources, incentivized market research programs, clinical reference and prescribing tools, promoted speaking opportunities, as well as CME and continuous learning modules on a variety of disease states and therapies.
The WSAVA represents more than 200,000 veterinarians worldwide through its 110 member associations and works to enhance standards of clinical care for companion animals. Its core activities include the development of WSAVA Global Guidelines in key areas of companion animal veterinary practice and lobbying on important issues affecting companion animal care worldwide.
You can count on Rushlight Ventures to maximize the value of your intellectual property (IP). Rushlight Ventures is a leading venture studio that specializes in the monetization of defense and dual-use intellectual property created by small and mid-sized businesses conducting federally sponsored research. We are both "IP type" and "monetization path" agnostic. We can pursue value creation from your IP via licenses, asset sales, startups, joint ventures, M&A, or internal business units. We work with IP of all varieties, including products, patents, trade secrets, proprietary relationships, and know-how. At Rushlight Ventures, we provide a range of consulting and support services, including: • Licensing • Asset sales • Joint ventures • Startup and spin-out creation • Commercialization planning and TABA support Companies primarily focused on delivering high-quality research, development, testing, and evaluation services (RDT&E) and other large programs may find it challenging to be equally adept at technology commercialization. Thats why Rushlight Ventures (RLV) originated as a venture studio in 2020 within Cornerstone Research Group (CRG), its sister company and a renowned government contractor for more than 25 years. Soon after forming the venture studio, leadership realized that CRG was not the only company grappling with transition and monetization difficulties, and RLV was spun off as an independent entity in 2021. Today, RLV successfully bridges the gap between RDT&E and commercialization through its seasoned team. RLV staff possess decades of experience in new technology development and commercialization, aerospace and defense RDT&E, new company formation, financing, licensing, and mergers and acquisitions. We have the knowledge and ability to take you from now to wow.
Precision AQ is a global life science commercialization vendor that specializes in Health Economics and Outcomes Research (HEOR), pricing, and market access consulting for pharmaceutical and biotech companies. Headquartered in New York City, the company operates with a strong emphasis on remote work. Precision AQ is dedicated to transforming patient lives by improving access to life-changing therapies through innovative strategies and data-driven approaches. The company offers a wide range of services to support clients throughout the healthcare journey. These include research, strategy, and product development, as well as marketing, branding, and public relations. Precision AQ also focuses on generating evidence for HEOR, optimizing payer access, and facilitating investor relations. Their expertise helps clients navigate the complexities of the market and enhance their presence among healthcare professionals and patients.